Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 77Carcinoma, Non-Small-Cell Lung 64Lung Neoplasms 31Hodgkin Disease 13Lymphoma 11Neoplasm Metastasis 10Recurrence 8Lymphoma, Non-Hodgkin 8Prostatic Neoplasms 7Neoplasms 7Adenocarcinoma of Lung 7Uterine Cervical Neoplasms 5Sarcoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Mesothelioma, Malignant 4Lymphoma, Large B-Cell, Diffuse 4Breast Neoplasms, Male 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Burkitt Lymphoma 3Brain Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Cyclophosphamide 6Vincristine 5Etoposide 5Doxorubicin 5Radiotherapy 4Ifosfamide 4Filgrastim 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Neoadjuvant Therapy 2Epirubicin 2Dactinomycin 2Cisplatin 2Chemotherapy, Adjuvant 2Brachytherapy 2tanespimycin 1prexasertib 1pazopanib 1ganitumab 1fludarabine phosphate 1exatecan 1cixutumumab 1Vinorelbine 1Topotecan 1Thiotepa 1Taxes 1Tacrolimus 1Sunitinib 1Sirolimus 1Ramucirumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Desmoplastic Small Round Cell Tumor × Vinorelbine × Clear all
NCT04145349 2026-05-11

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Eli Lilly and Company

Phase 1/2 Completed
30 enrolled 16 charts
Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡